PTGS2 and breast carcinoma: Since we observed generally lower levels of COX-2 related enzymes with clofibrate treatment in breast cancer cells, we further evaluated the effect of clofibrate treatment on the enzyme and receptor levels of the 5LO inflammatory pathway (Figure 6A and 6B).